Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals

Biotechnology and Bioengineering

Volumn 108, Issue 5, 2011, Pages 1056-1067

  Marek, Martin ^a,b,c   Van Oers, Monique M ^a   Devaraj, Feana Francis ^a   Vlak, Just M ^a   Merten, Otto Wilhelm ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b GÉNÉTHON   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Autographa californica MNPV; Baculovirus expression system; Biopharmaceuticals; Insect cells; Virus particles; vp80

Indexed keywords

CELL CULTURE; PLANTS (BOTANY); RECOMBINANT PROTEINS; VIRUSES;

AUTOGRAPHA CALIFORNICA; BACULOVIRUS EXPRESSION SYSTEMS; BIOPHARMACEUTICALS; INSECT CELLS; VIRUS PARTICLES; VP80;

GENE EXPRESSION;

BACULOVIRUS VECTOR; DRUG; RECOMBINANT PROTEIN;

ARTICLE; AUTOGRAPHA CALIFORNICA; BACULOVIRUS; BIOENGINEERING; DRUG MANUFACTURE; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; INSECT CELL; NONHUMAN; POLYHEDROSIS VIRUS; PROTEIN EXPRESSION; VIRION; VIRUS GENE; VIRUS RELEASE;

AUTOGRAPHA CALIFORNICA; AUTOGRAPHA CALIFORNICA MNPV; HEXAPODA; NUCLEOPOLYHEDROVIRUS;

EID: 79953156000     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23028     Document Type: Article

References (42)

1. Abe T, Matsuura Y. 2010. Host innate immune responses induced by baculovirus in mammals. Curr Gene Ther 10:226-231.
2. Abe T, Kaname Y, Wen X, Tani H, Moriishi K, Uematsu S, Takeuchi O, Ishii KJ, Kawai T, Akira S, Matsuura Y. 2009. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol 83:7629-7640.
3. Ahrens U, Kaden V, Drexler C, Visser N. 2000. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis® Pesti in pregnant sows. Vet Microbiol 77:83-97.
4. Beer M, Reimann I, Hoffmann B, Depner K. 2007. Novel marker vaccines against classical swine fever. Vaccine 25:5665-5670.
5. Blanchard P, Mahé D, Cariolet R, Keranflec'h A, Baudouard MA, Cordioli P, Albina E, Jestin A. 2003. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565-4575.
6. Chen PH, Ornelles DA, Shenk T. 1993. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J Virol 67:3507-3514.
7. Cohen DPA, Marek M, Davies BG, Vlak JM, van Oers MM. 2009. Encyclopedia of Autographa californica nucleopolyhedrovirus genes. Virol Sin 24:359-414.
8. Cox MMJ, Hollister JR. 2009. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 37:182-189.
9. Dai X, Willis LG, Palli SR, Theilmann DA. 2005. Tight transcriptional regulation of foreign genes in insect cells using an ecdysone receptor-based inducible system. Protein Expr Purif 42:236-245.
10. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97:6640-6645.
11. Fric J, Marek M, Hrusková V, Holán V, Forstová J. 2008. Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration. Vaccine 26:3242-3251.
12. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. 2006. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
13. Jarvis DL, Richard RB, Murray PD. 2009. Baculovirus-insect cell expression systems. Meth Enzymol 463:191-222.
14. Jenny C, Toublanc E, Danos O, Merten O-W. 2005. Evaluation of a serum-free medium for the production of rAAV-2 using HeLa derived producer cells. Cytotechnology 49:11-23.
15. Kenoutis C, Efrose RC, Swevers L, Lavdas AA, Gaitanou M, Matsas R, Iatrou K. 2006. Baculovirus-mediated gene delivery into mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 80:4135-4146.
16. Kitajima M, Takaku H. 2008. Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin Vaccine Immunol 15:376-378.
17. Kost TA, Condreay JP, Jarvis DL. 2005. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567-575.
18. Li X, Pang A, Lauzon HA, Sohi SS, Arif BM. 1997. The gene encoding the capsid protein P82 of the Choristoneura fumiferana multicapsid nucleopolyhedrovirus: Sequencing, transcription and characterization by immunoblot analysis. J Gen Virol 78:2665-2673.
19. Lopez MG, Alfonso V, Carrillo E, Taboga O. 2009. Trans-complementation of polyhedrin by a stably transformed Sf9 insect cell line allows occ-baculovirus occlusion and larval per os infectivity. J Biotechnol 145:199-205.
20. Lu A, Carstens EB. 1992. Nucleotide sequence and transcriptional analysis of the p80 gene of Autographa californica nuclear polyhedrosis virus: A homologue of the Orgyia pseudotsugata nuclear polyhedrosis virus capsid-associated gene. Virology 190:201-209.
21. Luckow VA, Lee SC, Barry GF, Olins PO. 1993. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol 67:4566-4579.
22. Lung O, Westenberg M, Vlak JM, Zuidema D, Blissard GW. 2002. Pseudotyping Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64. J Virol 76:5729-5736.
23. Mäkelä AR, Tuusa JE, Volkman LE, Oker-Blom C. 2008. Occlusion-derived baculovirus: Interaction with human cells and evaluation of the envelope protein P74 as a surface display platform. J Biotechnol 135:145-156.
24. Muller R, Pearson MN, Russell RLQ, Rohrmann GF. 1990. A capsid-associated protein of the multicapsid nuclear polyhedrosis virus of Orgyia pseudotsugata: Genetic location, sequence, transcriptional mapping, and immunocytochemical characterization. Virology 176:133-144.
25. Murges D, Kremer A, Knebel-Morsdorf D. 1997. Baculovirus transactivator IE1 is functional in mammalian cells. J Gen Virol 78:1507-1510.
26. Oualikene W, Lamoureux L, Weber JM, Massie B. 2000. Protease-deleted adenovirus vectors and complementing cell lines: Potential applications of single-round replication mutants for vaccination and gene therapy. Hum Gene Ther 11:1341-1353.
27. Peng K, van Oers MM, Hu ZH, van Lent JWM, Vlak JM. 2010. Baculovirus per os infectivity factors form a complex on the surface of occlusion-derived virus. J Virol 84:9497-9504.
28. Pijlman GP, Roode EC, Fan XX, Roberts LO, Belsham GJ, Vlak JM, van Oers MM. 2006. Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript. J Biotechnol 123:13-21.
29. Pillay S, Meyers A, Williamson AL, Rybicki EP. 2009. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system. Biotechnol Prog 25:1153-1160.
30. Ramadan N, Flockhart I, Booker M, Perrimon N, Mathey-Prevot B. 2007. Design and implementation of high-throughput RNAi screens in cultured Drosophila cells. Nat Protoc 2:2245-2264.
31. Slack J, Arif BM. 2006. The baculoviruses occlusion-derived virus: Virion structure and function. Adv Virus Res 69:99-165.
32. Smith RH, Levy JR, Kotin RM. 2009. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 17:1888-1896.
33. Summers MD, Bonning BC, Maramorosch K, Shatkin AJ. 2006. Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv Virus Res 68:3-73.
34. Suzuki N, Nonaka H, Tsuge Y, Inui M, Yukawa H. 2005. Multiple large segment deletion method for Corynebacterium glutamicum. Appl Microbiol Biotechnol 69:151-161.
35. Tang XD, Xu YP, Yu LI, Lang GJ, Tian CH, Zhao JF, Zhang CX. 2008. Characterization of a Bombyx mori nucleopolyhedrovirus with Bmvp80 disruption. Virus Res 138:81-88.
36. Tjia ST, Meyer zu, Altenschildesche G, Doerfler W. 1983. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125:107-117.
37. Urabe M, Ding C, Kotin RM. 2002. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13:1935-1943.
38. van Lent JWM, Groenen JTM, Klinge-Rood EC, Rohrmann GF, Zuidema D, Vlak JM. 1990. Localization of the 34kDa polyhedron envelope protein in Spodoptera frugiperda cells infected with Autographa california nuclear polyhedrosis virus. Arch Virol 111:103-114.
39. van Oers MM. 2006. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res 68:193-253.
40. van Oers MM, Vlak JM. 2007. Baculovirus genomics. Curr Drug Targ 8:1051-1068.
41. Wen Z, Ye L, Gao Y, Pan L, Dong K, Bu Z, Compans RW, Yang C. 2009. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res 84:215-224.
42. Yin F, Wang M, Tan Y, Deng F, Vlak JM, Hu Z, Wang H. 2008. A functional F analogue of AcMNPV GP64 from the Agrotis segetum granulovirus. J Virol 82:8922-8926.